{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T02:34:02Z","timestamp":1715567642023},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T00:00:00Z","timestamp":1410912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s40266-014-0215-z","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T16:58:08Z","timestamp":1410973088000},"page":"805-813","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Current Use of Domperidone and Co-prescribing of Medications that Increase Its Arrhythmogenic Potential Among Older Adults: A Population-Based Cohort Study in Ontario, Canada"],"prefix":"10.1007","volume":"31","author":[{"given":"Carlos","family":"Rojas-Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne L.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadas D.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine R.","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Pondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula A.","family":"Rochon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Marras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"issue":"4","key":"215_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1345\/aph.18003","volume":"33","author":"JA Barone","year":"1999","unstructured":"Barone JA. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother. 1999;33(4):429\u201340.","journal-title":"Ann Pharmacother."},{"issue":"5","key":"215_CR2","first-page":"457","volume":"135","author":"MC Champion","year":"1986","unstructured":"Champion MC, Hartnett M, Yen M. Domperidone, a new dopamine antagonist. CMAJ. 1986;135(5):457\u201361.","journal-title":"CMAJ."},{"issue":"9","key":"215_CR3","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1572-0241.2007.01255.x","volume":"102","author":"SC Reddymasu","year":"2007","unstructured":"Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007;102(9):2036\u201345.","journal-title":"Am J Gastroenterol."},{"issue":"4 Suppl 4","key":"215_CR4","first-page":"S1","volume":"39","author":"D Grimes","year":"2012","unstructured":"Grimes D, Gordon J, Snelgrove B, et al. Canadian guidelines on parkinson\u2019s disease. Can J Neurol Sci. 2012;39(4 Suppl 4):S1\u201330.","journal-title":"Can J Neurol Sci."},{"key":"215_CR5","unstructured":"Mathivanan M. Association of domperidone maleate with serious abnormal heart rhythms and sudden death (cardiac arrest). Health Canada Public Communication Web site. http:\/\/www.healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2012\/14118a-eng.php . Published 2012. Accessed 5 May 2014."},{"issue":"9","key":"215_CR6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/pds.2016","volume":"19","author":"CB Johannes","year":"2010","unstructured":"Johannes CB, Varas-Lorenzo C, McQuay LJ, Midkiff KD, Fife D. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case\u2013control study. Pharmacoepidemiol Drug Saf. 2010;19(9):881\u20138.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"11","key":"215_CR7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2165\/11536840-000000000-00000","volume":"33","author":"C Noord van","year":"2010","unstructured":"van Noord C, Dieleman JP, van Herpen G, Verhamme K, Sturkenboom MC. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case\u2013control study in the Netherlands. Drug Saf. 2010;33(11):1003\u201314.","journal-title":"Drug Saf."},{"issue":"2","key":"215_CR8","first-page":"67","volume":"10","author":"AR Levy","year":"2003","unstructured":"Levy AR, O\u2019Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario drug benefit database. Can J Clin Pharmacol. 2003;10(2):67\u201371.","journal-title":"Can J Clin Pharmacol."},{"issue":"3","key":"215_CR9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","volume":"25","author":"JE Hux","year":"2002","unstructured":"Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25(3):512\u20136.","journal-title":"Diabetes Care."},{"issue":"5","key":"215_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15412550903140865","volume":"6","author":"AS Gershon","year":"2009","unstructured":"Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physician diagnosed COPD in health administrative databases. COPD. 2009;6(5):388\u201394.","journal-title":"COPD."},{"issue":"3","key":"215_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.24095\/hpcdp.33.3.06","volume":"33","author":"SE Schultz","year":"2013","unstructured":"Schultz SE, Rothwell DM, Chen Z, Tu K. Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records. Chronic Dis Inj Can. 2013;33(3):160\u20136.","journal-title":"Chronic Dis Inj Can."},{"issue":"10","key":"215_CR12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013\u201322.","journal-title":"N Engl J Med."},{"issue":"7","key":"215_CR13","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/bjp.2008.238","volume":"154","author":"DM Roden","year":"2008","unstructured":"Roden DM. Cellular basis of drug-induced torsades de pointes. Br J Pharmacol. 2008;154(7):1502\u20137.","journal-title":"Br J Pharmacol."},{"issue":"5","key":"215_CR14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00246-004-0922-z","volume":"26","author":"CM Rocha","year":"2005","unstructured":"Rocha CM, Barbosa MM. QT interval prolongation associated with the oral use of domperidone in an infant. Pediatr Cardiol. 2005;26(5):720\u20133.","journal-title":"Pediatr Cardiol."},{"issue":"3","key":"215_CR15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2125.2011.04093.x","volume":"73","author":"MJ Boyce","year":"2012","unstructured":"Boyce MJ, Baisley KJ, Warrington SJ. Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study. Br J Clin Pharmacol. 2012;73(3):411\u201321.","journal-title":"Br J Clin Pharmacol."},{"key":"215_CR16","unstructured":"Combined list of all QTdrugs and the list of drugs to avoid for patients with congenital long QT syndrome. Credible Meds Web site. https:\/\/www.crediblemeds.org\/everyone\/composite-list-all-qtdrugs\/ . Updated 2014. Accessed 8 July 2014."},{"issue":"3","key":"215_CR17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/FJC.0b013e31827afd0d","volume":"61","author":"LM Hondeghem","year":"2013","unstructured":"Hondeghem LM. Domperidone: Limited benefits with significant risk for sudden cardiac death. J Cardiovasc Pharmacol. 2013;61(3):218\u201325.","journal-title":"J Cardiovasc Pharmacol."},{"issue":"3","key":"215_CR18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/bdd.343","volume":"24","author":"K Tsujikawa","year":"2003","unstructured":"Tsujikawa K, Dan Y, Nogawa K, et al. Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A. Biopharm Drug Dispos. 2003;24(3):105\u201314.","journal-title":"Biopharm Drug Dispos."},{"key":"215_CR19","unstructured":"Flockhart D. Drug interactions: cytochrome P450 drug interaction table. Indiana University School of Medicine (2007) Web site. http:\/\/medicine.iupui.edu\/clinpharm\/ddis\/clinical-table\/ . Accessed 5 May 2014."},{"key":"215_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/1-59259-924-9:041","volume-title":"Infectious disease: drug interactions in infectious diseases","author":"SR Penzak","year":"2005","unstructured":"Penzak SR. Infectious disease: drug interactions in infectious diseases. In: Piscitelli SC, Rodvold KA, editors. Infectious disease: drug interactions in infectious diseases. 2nd ed. Totowa: Humana Press Inc.; 2005. p. 41.","edition":"2"},{"issue":"11","key":"215_CR21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245\u201351.","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"215_CR22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng.364","volume":"41","author":"C Newton-Cheh","year":"2009","unstructured":"Newton-Cheh C, Eijgelsheim M, Rice KM, et al. Common variants at ten loci influence QT interval duration in the QTGEN study. Nat Genet. 2009;41(4):399\u2013406.","journal-title":"Nat Genet."},{"key":"215_CR23","unstructured":"CMDh confirms recommendations on restricting use of domperidone-containing medicines: European commission to take final legal decision. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2014\/04\/WC500165651.pdf . Published 25 April 2014. Updated 2014. Accessed 5 May 2014."},{"key":"215_CR24","volume-title":"Domperidone: upper gastrointestinal motility modifier","author":"Compendium of Pharmaceuticals and Specialities","year":"2009","unstructured":"Compendium of Pharmaceuticals and Specialities. Domperidone: upper gastrointestinal motility modifier. 2014th ed. Toronto: Canadian Pharmacists Association; 2009.","edition":"2014"},{"issue":"7","key":"215_CR25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-111-7-549","volume":"111","author":"R Lazzara","year":"1989","unstructured":"Lazzara R. Amiodarone and torsade de pointes. Ann Intern Med. 1989;111(7):549\u201351.","journal-title":"Ann Intern Med."},{"issue":"7","key":"215_CR26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1745-7254.2007.00562.x","volume":"28","author":"JJ Duan","year":"2007","unstructured":"Duan JJ, Ma JH, Zhang PH, Wang XP, Zou AR, Tu DN. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain. Acta Pharmacol Sin. 2007;28(7):959\u201367.","journal-title":"Acta Pharmacol Sin."},{"issue":"2","key":"215_CR27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jat.1252","volume":"28","author":"SJ Park","year":"2008","unstructured":"Park SJ, Kim KS, Kim EJ. Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656. J Appl Toxicol. 2008;28(2):104\u201311.","journal-title":"J Appl Toxicol."},{"issue":"3","key":"215_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FJC.0b013e31827e2573","volume":"61","author":"V Michaud","year":"2013","unstructured":"Michaud V, Turgeon J. Domperidone and sudden cardiac death: how much longer should we wait? J Cardiovasc Pharmacol. 2013;61(3):215\u20137.","journal-title":"J Cardiovasc Pharmacol."},{"issue":"6","key":"215_CR29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.coph.2006.07.004","volume":"6","author":"N Ahmad","year":"2006","unstructured":"Ahmad N, Keith-Ferris J, Gooden E, Abell T. Making a case for domperidone in the treatment of gastrointestinal motility disorders. Curr Opin Pharmacol. 2006;6(6):571\u20136.","journal-title":"Curr Opin Pharmacol."},{"issue":"6","key":"215_CR30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.parkreldis.2013.02.004","volume":"19","author":"NM Malek","year":"2013","unstructured":"Malek NM, Grosset KA, Stewart D, Macphee GJ, Grosset DG. Prescription of drugs with potential adverse effects on cardiac conduction in parkinson\u2019s disease. Parkinsonism Relat Disord. 2013;19(6):586\u20139.","journal-title":"Parkinsonism Relat Disord."}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-014-0215-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-014-0215-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-014-0215-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T08:15:08Z","timestamp":1650183308000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-014-0215-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,17]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s40266-014-0215-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,17]]}}}